Vaccines & Immunogenicity World Congress 2023 Europe
London, United Kingdom
Day 2 - Tuesday 14th November 2023
- Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines
- Combinations of immuno-stimulatory or immuno-modulatory adjuvants for the development of novel adjuvants for cancer immunotherapy
VACCINES AGAINST CANCER AND EMERGING DISEASES
- Oncolytic virotherapy and immune checkpoint blockade agents to enhance the anti tumor response
- Adapting dendritic cell-based vaccine for pancreatic cancer
- Novel vaccine designs that employ strategies to prevent HIV acquisition and development of therapeutic vaccine
- Dendritic cell activation and HIV vaccine effectiveness enhanced through nanoparticle vaccination
- Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine
- Development of therapeutic antibodies against dengue virus
VACCINES AGAINST CANCER AND EMERGING DISEASES
- B and T cell epitope-based peptides from conserved and whole protein sequences of Ebola virus as vaccine targets
- Identification of cell-targeting antibodies in immunity to Ebola
- Targeting conserved B and Tcell epitopes for developing broadly protective or “universal” influenza virus vaccines
- Developing quadrivalent virus like particle influenza vaccine from plants
- Status of vaccine research and development of vaccines for tuberculosis
- Complement component 3 as new paradigm in tuberculosis vaccine
- A retrospective analysis of the Alzheimer's disease vaccine progress
- Focus on amyloid-β, α-synuclein, and tau for the treatment of neurodegenerative disorders
